Blair William & Co. IL lifted its stake in shares of Expeditors International of Washington, Inc. (NASDAQ:EXPD – Free Report) by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,776 shares of the transportation company’s stock after purchasing an additional 95 shares during the period. Blair William & Co. IL’s holdings in Expeditors International of Washington were worth $970,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the stock. Crewe Advisors LLC purchased a new position in Expeditors International of Washington in the 1st quarter valued at approximately $25,000. Optiver Holding B.V. purchased a new position in Expeditors International of Washington in the 4th quarter valued at approximately $27,000. Innealta Capital LLC purchased a new position in Expeditors International of Washington in the 2nd quarter valued at approximately $31,000. Family Firm Inc. purchased a new position in Expeditors International of Washington in the 2nd quarter valued at approximately $35,000. Finally, ORG Partners LLC grew its stake in Expeditors International of Washington by 752.0% in the 1st quarter. ORG Partners LLC now owns 426 shares of the transportation company’s stock valued at $51,000 after buying an additional 376 shares in the last quarter. Hedge funds and other institutional investors own 94.02% of the company’s stock.
Expeditors International of Washington Stock Performance
NASDAQ EXPD opened at $128.08 on Wednesday. Expeditors International of Washington, Inc. has a 52-week low of $107.03 and a 52-week high of $131.17. The company has a market capitalization of $18.09 billion, a P/E ratio of 27.14, a P/E/G ratio of 5.59 and a beta of 0.97. The company has a fifty day moving average of $122.26 and a 200-day moving average of $120.57.
Wall Street Analyst Weigh In
EXPD has been the subject of a number of recent research reports. Wolfe Research upgraded shares of Expeditors International of Washington from an “underperform” rating to a “peer perform” rating in a research note on Tuesday, May 28th. UBS Group upgraded shares of Expeditors International of Washington from a “sell” rating to a “neutral” rating and boosted their price target for the company from $95.00 to $137.00 in a research report on Thursday, August 1st. Robert W. Baird boosted their price target on shares of Expeditors International of Washington from $118.00 to $126.00 and gave the company a “neutral” rating in a research report on Wednesday, July 3rd. Bank of America boosted their price target on shares of Expeditors International of Washington from $131.00 to $132.00 and gave the company a “neutral” rating in a research report on Monday, July 22nd. Finally, Benchmark restated a “hold” rating on shares of Expeditors International of Washington in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a sell rating and ten have given a hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $116.00.
Read Our Latest Stock Analysis on EXPD
About Expeditors International of Washington
Expeditors International of Washington, Inc, together with its subsidiaries, provides logistics services worldwide. The company offers airfreight services, such as air freight consolidation and forwarding; ocean freight and ocean services, including ocean freight consolidation, direct ocean forwarding, and order management; customs brokerage, import, intra-continental ground transportation and delivery, and warehousing and distribution services; and customs clearance, purchase order management, vendor consolidation, time-definite transportation services, temperature-controlled transit, cargo insurance, specialized cargo monitoring and tracking, and other supply chain solutions.
Featured Articles
- Five stocks we like better than Expeditors International of Washington
- How to Capture the Benefits of Dividend Increases
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Warren Buffett Stocks to Buy Now
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is Forex and How Does it Work?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Expeditors International of Washington Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expeditors International of Washington and related companies with MarketBeat.com's FREE daily email newsletter.